Spots Global Cancer Trial Database for molecular biomarkers
Every month we try and update this database with for molecular biomarkers cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma | NCT01684449 | Advanced Soft T... | Gemcitabine + R... | 18 Years - 70 Years | Grupo Espanol de Investigacion en Sarcomas | |
Lung Cancer Registry for Lung Cancer Patients | NCT03276429 | Lung Cancer | 18 Years - | Oncology Center of Biochemical Education And Research | ||
Lung Cancer Registry for Lung Cancer Patients | NCT03276429 | Lung Cancer | 18 Years - | Oncology Center of Biochemical Education And Research | ||
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers. | NCT05371756 | Cancer | - | Baylor Research Institute | ||
Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor | NCT03667092 | Midgut Neuroend... | non-drug interv... | 18 Years - | University Hospital, Toulouse | |
Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma | NCT01684449 | Advanced Soft T... | Gemcitabine + R... | 18 Years - 70 Years | Grupo Espanol de Investigacion en Sarcomas | |
Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor | NCT03667092 | Midgut Neuroend... | non-drug interv... | 18 Years - | University Hospital, Toulouse |